Swiss National Bank Has $121.56 Million Stock Holdings in Kenvue Inc. $KVUE

Swiss National Bank lifted its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 7.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,808,046 shares of the company’s stock after purchasing an additional 400,700 shares during the period. Swiss National Bank’s holdings in Kenvue were worth $121,562,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in KVUE. Truvestments Capital LLC acquired a new position in Kenvue in the first quarter valued at approximately $37,000. Trust Co. of Vermont increased its stake in shares of Kenvue by 266.8% in the 2nd quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock valued at $33,000 after acquiring an additional 1,150 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd increased its stake in shares of Kenvue by 378.5% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company’s stock valued at $39,000 after acquiring an additional 1,287 shares in the last quarter. Bank Julius Baer & Co. Ltd Zurich lifted its position in shares of Kenvue by 120.6% during the 1st quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,699 shares of the company’s stock valued at $41,000 after acquiring an additional 929 shares during the period. Finally, Ransom Advisory Ltd bought a new position in Kenvue during the first quarter worth $56,000. 97.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently commented on KVUE shares. Citigroup reduced their target price on Kenvue from $20.00 to $17.00 and set a “neutral” rating for the company in a research note on Thursday, October 9th. UBS Group reduced their price objective on Kenvue from $23.00 to $17.00 and set a “neutral” rating for the company in a research note on Wednesday, October 8th. Johnson Rice restated a “neutral” rating on shares of Kenvue in a report on Tuesday, October 28th. Deutsche Bank Aktiengesellschaft set a $18.00 target price on Kenvue in a research report on Friday, October 24th. Finally, Redburn Partners set a $22.00 price target on shares of Kenvue in a research report on Friday, September 26th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, twelve have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Kenvue currently has an average rating of “Hold” and an average target price of $20.23.

Kenvue Trading Up 3.0%

NYSE KVUE opened at $16.63 on Friday. The company has a current ratio of 0.98, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. The business has a fifty day simple moving average of $16.17 and a 200 day simple moving average of $19.80. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $25.17. The firm has a market capitalization of $31.86 billion, a P/E ratio of 22.17, a PEG ratio of 2.31 and a beta of 0.71.

Kenvue (NYSE:KVUE) last posted its earnings results on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.01. The firm had revenue of $3.76 billion during the quarter, compared to analyst estimates of $3.83 billion. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The business’s revenue was down 3.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.28 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, analysts predict that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th will be given a dividend of $0.2075 per share. The ex-dividend date of this dividend is Wednesday, November 12th. This represents a $0.83 annualized dividend and a dividend yield of 5.0%. Kenvue’s dividend payout ratio (DPR) is currently 110.67%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.